Navigation Links
Mesa Laboratories, Inc. Added to the Russell Microcap Index
Date:7/7/2008

LAKEWOOD, Colo., July 7 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) announced today that it was added to the Russell Microcap(R) Index when Russell Investments reconstituted its comprehensive family of U.S. indexes on June 27, 2008.

Membership in the Russell Microcap, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies.

"We are pleased with our inclusion in this index, which reflects our continued positive momentum of sales and earnings," said John J. Sullivan, President and COO. "Russell is an industry leader for stock indexes, and we expect our inclusion will generate greater interest in our stock among institutional investors."

Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000(R) Index and Russell Microcap. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

About Russell:

Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $213 billion in asse
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
5. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
10. Bond Laboratories, Inc. Announces 2-for-1 Forward Split
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...D, Calif., Jan. 8 (Nas...") announced today that it has submitted an Invest...the US Food and Drug Administration ("FDA" or the ...") study of the Levacor(TM) Ventricular Assist Dev... detailed device information, including design and...
(Date:1/8/2009)...RK, Jan. 8 We hear it everywhere: ... is a carbon footprint, and how can you reduce y...akes is a little thought and planning to bring it ...YSE: SI ) at: http://media.medialink.com/WebNR....n access video, audio, text, graphics and photos f...
(Date:1/8/2009)... Yet another reason to use a tread... Phoenix, AZ (PRWEB) Januar...ff by the medical community warning of America,s r... to disease. The National Cancer Institute complet...ant relationship between excess weight gain and ov...
(Date:1/8/2009)... has been one of the most amazing recovery cases I...Michael Kronenberger, MD, Otolaryngology, Dallas, ...he span of four years, Wally Hogland suffered a st... advanced stage IV cancer. , , "When my doctor ...nd, tears welling up in his eyes at the painful re...
Breaking Medicine News(10 mins):Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:One Man's Determined Journey to Remission and a Renewed Sense of Faith 2
...fforts should be made to stop the spread of TB as ...s of tuberculosis in theworld were resistant to m...okesperson. On average, a patient infected with d...004 is foundto show more resistant to drugs than a...
...s Mandy Moore recently revealed that her latest al...pression. Moore said that penning songs for her n...e side of life. The 23-year-old was left feeling ...ight to come out from the blues with new album, an...
...s national AIDS conference wrapped up on Friday wi...e made more widely available and for more research...female condoms both needed to be more readily obta...laration document which also outlined new suggesti...
... has tested positive for the deadly H5N1 bird flu ...iday. Authorities said laboratory tests had confi...ral New Territories area, was infected with the ki...l contact with wild birds and live poultry. It was...
Other Medicine News:Health News:WHO Cautions Against Spread of Drug-resistant Tuberculosis. 2Health News:South African AIDS Delegates Issue Contraception Call 2
(Date:1/3/2009)... , , ROSEMONT, Ill., Jan. 2 /PRNewswire-USNewsw...ing technology providing an increasing number of c...ck pain according to an article in the January 200...Orthopaedic Surgeons ( http://www.jaaos.org/ ). I...dditional technical developments will allow MRI to...
(Date:12/27/2008)..., Dec. 23 Warner Chilcot...ne of its subsidiaries and Mayne Pharma Internatio...Inc., have filed lawsuits against each of Mutual P...maceuticals Inc. ("Mylan") and Impax Laboratories,...trict of New Jersey for infringement of Mayne,s U....
(Date:12/17/2008)...t in development and validation of non-animal alte...c. 17 MatTek Corporation today ann...e (ESAC) endorsed the scientific validity of the M...November meeting. ESAC concluded that the Modifie...ity for the prediction of skin irritating and non-...
(Date:12/17/2008)...17 PEAK Surgical, Inc., a medical,...ssection system based on a,proprietary technology...inistration (FDA) has granted the company 510(k) c... cutting and coagulation of soft tissue during,pl...t), gynecologic,orthopedic, arthroscopic, spinal...
Breaking Medicine Technology:MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3EpiDerm's Skin Irritation Test Fully Validated in European Union 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4AUDIO from Medialink and Pfizer 3A The 20th Annual American Diabetes Alert Day Reminds Us to Learn if We Are at Risk 15122 1AUDIO from Medialink and Pfizer 3A The 20th Annual American Diabetes Alert Day Reminds Us to Learn if We Are at Risk 15122 2MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 1MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 2MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 3North American Insurance Leaders Inc Announces Results of the Annual Meeting of Stockholders 15115 1International Eye Foundation Announces Partnership with Newport Creative Communications 15110 1International Eye Foundation Announces Partnership with Newport Creative Communications 15110 2
...CELONA, Spain--(BUSINESS WIRE)--Apr 11, 2007 - New...revir (VX-950), one of,the most advanced investiga...of hepatitis C virus (HCV) infection, will be pres...ssociation for the,Study of the Liver (EASL) in Ba...d to telaprevir have been accepted for presentatio...
...hlights key data at the 42nd annual meeting of the...EASL), KENILWORTH, N.J., April 11, 2007 /PRNewswir...rms its commitment to advancing,the science and tr...on with several key data presentations at the Euro... 42nd annual meeting,in Barcelona, Spain, April 11...
Other Medicine Technology:Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 2Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 3Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 4Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 5Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 7
...icrotome designed for manual sectioning of primari...microtome's low maintenance and backlash-free prec...ty sections of reproducible thickness even when se...n two different basic versions and in different co...
...with low-maintenance cross-roller-bearing guideway... in routine histopathology laboratories. The SM200...sectioning applications. The instrument is availab...microtome sectioning requirements or can be custom...
...t automatic glass coverslipper designed for applic...e instrument is capable of coverslipping up to 400...g capabilities. The slide baskets are capable of c...ive operation is made easy via a touchpad. Coversl...
Hydrophobic Acrylic Intraocular Lens, AC depth: 5.3.
Medicine Products: